Related references
Note: Only part of the references are listed.Pancreatic Adenocarcinoma with Venous Involvement: Is Up-Front Synchronous Portal-Superior Mesenteric Vein Resection Still Justified? A Survey of the Association Fran‡aise de Chirurgie
Jean Robert Delpero et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Preoperative endoscopic ultrasound-guided fine needle aspiration does not impair survival of patients with resected pancreatic cancer
Saowanee Ngamruengphong et al.
GUT (2015)
Laparoscopic Versus Open Distal Pancreatectomy for Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis
Claudio Ricci et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2015)
Whole genomes redefine the mutational landscape of pancreatic cancer
Nicola Waddell et al.
NATURE (2015)
Pathological and Molecular Evaluation of Pancreatic Neoplasms
Arvind Rishi et al.
SEMINARS IN ONCOLOGY (2015)
Premalignant Cystic Neoplasms of the Pancreas
Vikas Dudeja et al.
SEMINARS IN ONCOLOGY (2015)
Demographics, Epidemiology, and Inheritance of Pancreatic Ductal Adenocarcinoma
Theresa Pluth Yeo
SEMINARS IN ONCOLOGY (2015)
Endoscopic and Operative Palliation Strategies for Pancreatic Ductal Adenocarcinoma
Alexander Stark et al.
SEMINARS IN ONCOLOGY (2015)
Risk factors for pancreatic cancer: a summary review of meta-analytical studies
Patrick Maisonneuve et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
European cancer mortality predictions for the year 2014
M. Malvezzi et al.
ANNALS OF ONCOLOGY (2014)
pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104
Steffen Ormanns et al.
BMC CANCER (2014)
Second-Line Oxaliplatin, Folinic Acid, and Fluorouracil Versus Folinic Acid and Fluorouracil Alone for Gemcitabine-Refractory Pancreatic Cancer: Outcomes From the CONKO-003 Trial
Helmut Oettle et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial
William Greenhalf et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Pancreatic Ductal Adenocarcinoma Radiology Reporting Template: Consensus Statement of the Society of Abdominal Radiology and the American Pancreatic Association
Mahmoud M. Al-Hawary et al.
RADIOLOGY (2014)
Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: A consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)
Johanna A. M. G. Tol et al.
SURGERY (2014)
Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS)
Maximilian Bockhorn et al.
SURGERY (2014)
Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments
Irene Esposito et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens
Jean Robert Delpero et al.
HPB (2014)
Comprehensive Genomic Profiling of Pancreatic Acinar Cell Carcinomas Identifies Recurrent RAF Fusions and Frequent Inactivation of DNA Repair Genes
Juliann Chmielecki et al.
CANCER DISCOVERY (2014)
Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: A meta-analysis of randomised trials
Domenico Ciliberto et al.
EUROPEAN JOURNAL OF CANCER (2013)
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial
Somnath Mukherjee et al.
LANCET ONCOLOGY (2013)
Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head
Quentin Denost et al.
HPB (2013)
Management of cancer pain: ESMO Clinical Practice Guidelines
C. I. Ripamonti et al.
ANNALS OF ONCOLOGY (2012)
Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies
S. C. Larsson et al.
BRITISH JOURNAL OF CANCER (2012)
Levels of Gemcitabine Transport and Metabolism Proteins Predict Survival Times of Patients Treated With Gemcitabine for Pancreatic Adenocarcinoma
Raphael Marechal et al.
GASTROENTEROLOGY (2012)
Long-Term Results of Resection of Adenocarcinoma of the Body and Tail of the Pancreas Using Radical Antegrade Modular Pancreatosplenectomy Procedure
Jonathan B. Mitchem et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2012)
Perioperative mortality after pancreatectomy: A risk score to aid decision-making
Elizaveta Ragulin-Coyne et al.
SURGERY (2012)
Complete remission, in BRCA2 mutation carrier with metastatic pancreatic adenocarcinoma, treated with cisplatin based therapy
Amir Sonnenblick et al.
CANCER BIOLOGY & THERAPY (2011)
mTOR Inhibitor Treatment of Pancreatic Cancer in a Patient With Peutz-Jeghers Syndrome
Heinz-Josef Klumpen et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
Patrick J. Loehrer et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Neoadjuvant therapy in pancreatic adenocarcinoma: A meta-analysis of phase II trials
M. Mura Assifi et al.
SURGERY (2011)
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial
John P. Neoptolemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Randomized Phase II Study of Gemcitabine Plus Radiotherapy Versus Gemcitabine, 5-Fluorouracil, and Cisplatin Followed by Radiotherapy and 5-Fluorouracil for Patients With Locally Advanced, Potentially Resectable Pancreatic Adenocarcinoma
Jerome Landry et al.
JOURNAL OF SURGICAL ONCOLOGY (2010)
A Multicenter Analysis of Distal Pancreatectomy for Adenocarcinoma: Is Laparoscopic Resection Appropriate?
David A. Kooby et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2010)
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Shinichi Yachida et al.
NATURE (2010)
Preoperative Biliary Drainage for Cancer of the Head of the Pancreas
Niels A. van der Gaag et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages
Sonja Gillen et al.
PLOS MEDICINE (2010)
Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement
Ross A. Abrams et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement
Mark P. Callery et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
Amanda Blackford et al.
CLINICAL CANCER RESEARCH (2009)
The Hedgehog Pathway and Pancreatic Cancer
Manuel Hidalgo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Staging of Pancreatic Adenocarcinoma by Imaging Studies
Jimmie C. Wong et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2008)
672 patients with acinar cell carcinoma of the pancreas: a population-based comparison to pancreatic adenocarcinoma
Nicholas C. Wisnoski et al.
SURGERY (2008)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Systematic review, including meta-analyses, on the management of locally advanced pancreatic cancer using radiation/combined modality therapy
A. Sultana et al.
BRITISH JOURNAL OF CANCER (2007)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma -: A meta-analysis
S Bipat et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2005)
Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer
H Shinchi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer:: a randomised controlled trial
JP Neoptolemos et al.
LANCET (2001)
Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients
CA Dykewicz
CLINICAL INFECTIOUS DISEASES (2001)
Occupational exposures and pancreatic cancer:: a meta-analysis
IA Ojajärvi et al.
OCCUPATIONAL AND ENVIRONMENTAL MEDICINE (2000)